JURVIGO Trademark

Trademark Overview


On Wednesday, October 10, 2018, a trademark application was filed for JURVIGO with the United States Patent and Trademark Office. The USPTO has given the JURVIGO trademark a serial number of 88149295. The federal status of this trademark filing is REGISTERED as of Tuesday, April 6, 2021. This trademark is owned by Mezzion Pharma Co., Ltd.. The JURVIGO trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Educational services, namely, lectures, seminars, training and classes in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; education, namely, lectures, seminars, classes and training in the use of pharmaceuticals for cardiac and other health issues

Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation

Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes

Medical and pharmaceutical research for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease research, namely, single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation for medical research purposes; conducting clinical trials for others
jurvigo

General Information


Serial Number88149295
Word MarkJURVIGO
Filing DateWednesday, October 10, 2018
Status700 - REGISTERED
Status DateTuesday, April 6, 2021
Registration Number6311618
Registration DateTuesday, April 6, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 19, 2021

Trademark Statements


Goods and ServicesEducational services, namely, lectures, seminars, training and classes in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; education, namely, lectures, seminars, classes and training in the use of pharmaceuticals for cardiac and other health issues
Goods and ServicesPharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation
Goods and ServicesMedical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes
Goods and ServicesMedical and pharmaceutical research for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease research, namely, single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation for medical research purposes; conducting clinical trials for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateSaturday, October 20, 2018
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 20, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 1, 0001
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMezzion Pharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSeoul 06163
KR

Party NameMezzion Pharma Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSeoul 06167
KR

Party NameMezzion Pharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSeoul 06167
KR

Trademark Events


Event DateEvent Description
Thursday, January 24, 2019NON-FINAL ACTION WRITTEN
Saturday, October 13, 2018NEW APPLICATION ENTERED
Saturday, October 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 22, 2019ASSIGNED TO EXAMINER
Thursday, January 24, 2019NON-FINAL ACTION E-MAILED
Thursday, January 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 14, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 19, 2019ASSIGNED TO LIE
Friday, June 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 19, 2020TEAS PETITION TO AMEND BASIS RECEIVED
Monday, March 23, 2020SOU TEAS EXTENSION RECEIVED
Monday, March 23, 2020SOU EXTENSION 1 FILED
Monday, March 23, 2020SOU EXTENSION 1 GRANTED
Wednesday, March 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 15, 2020ASSIGNED TO PETITION STAFF
Friday, May 15, 2020PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, May 15, 2020ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Tuesday, May 19, 2020NOTICE OF ALLOWANCE CANCELLED
Tuesday, June 9, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, May 19, 20201(B) BASIS DELETED; NEW BASIS REQUESTED
Monday, December 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 10, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, July 10, 2020NON-FINAL ACTION WRITTEN
Friday, July 10, 2020NON-FINAL ACTION E-MAILED
Friday, July 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 19, 2021PUBLISHED FOR OPPOSITION
Tuesday, January 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 6, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, May 29, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, May 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 23, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, August 23, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Friday, August 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED